Skip to main content

Table 5 Response to DXM treatment protocol by our study group (n = 30)

From: The use of dexamethasone therapy for conservative management of chronic subdural hematomas: a question about efficacy and safety

Response to DXM treatment protocol

Total (n = 30) (%)

Favorable response

21 (70.0)

Unfavorable response

9 (30.0)

 ≤ 3 days

3/9 (33.3)

4–7 days

3/9 (33.3)

 > 7 days

3/9 (33.3)

  1. DXM dexamethasone, n number of patients